We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
-21.67%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
10 Year Est. Return
AUM
$128M
AUM Growth
-$38.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$109M 85.42%
750,000
NVAX icon
2
Novavax
NVAX
$1.35B
$13.8M 10.84%
66,810
XLRN
3
DELISTED
Acceleron Pharma
XLRN
$3.29M 2.57%
19,100
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$1.5M 1.18%
293,759

Similar funds

Foresite Capital Management I's Q3 2021 Portfolio in Review

As of Q3 2021, Foresite Capital Management I held 4 positions worth $128M, down 23% from $166M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Foresite Capital Management I opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I's ten largest holdings make up 100% of its $128M portfolio in Q3 2021.
  • Foresite Capital Management I opened 0 new positions and closed 0 in Q3 2021.
  • Foresite Capital Management I's portfolio value fell 23% quarter-over-quarter to $128M.

Based on Foresite Capital Management I's 13F filing for Q3 2021, filed 12 Nov 2021.